by synergycap1 | Jun 8, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Cancer, Capital, Diaz, Luis A., Jr., Drugs (Pharmaceuticals), Economics, Finance, Genetics and Heredity, Immune System, Keytruda, Non-Bank Loans, Pembrolizumab, Science (Journal), Tumors, Working Capital
The drug, Keytruda, is the first approved for patients with tumors with a particular genetic signature, wherever they appear in the body.
